Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

March 30, 2016

Study Completion Date

July 25, 2018

Conditions
Diabetic Neuropathy
Interventions
DRUG

γ-linoleic acid and placebo(Thioctic Acid)

"* γ-linoleic acid (Evoprim soft capsule) twice a day and 4 capsules at a time.~* Thioctic Acid(LipoA HR Tab. 600mg) placebo once a day and 1 tablet at a time."

DRUG

Thioctic Acid and placebo(γ-linoleic acid)

"* Thioctic Acid(LipoA HR Tab. 600mg) once a day and 1 tablet at a time.~* γ-linoleic acid (Evoprim soft capsule) placebo twice a day and 4 capsules at a time."

Trial Locations (11)

2156

Gachon University Gil Medical Center, Incheon

14754

Sejong hospital, Bucheon-si

31151

Soon chun hyang university hospital cheonan, Cheonan

38067

Dongguk university gyeongju hospital, Gyeongju

42472

Daegu Catholic University Medical Center, Daegu

49241

Pusan National University Hospital, Pusan

54907

Obesity Research Center of Chonbuk National University, Jeonju

01757

Inje university sanggye paik hospital, Seoul

03722

Yonsei univesity severance hospital, Seoul

06591

The catholic university of korea seoul st. mary's hospital, Seoul

07345

The catholic university of korea Yeouido st. mary's hospital, Seoul

All Listed Sponsors
lead

Chonbuk National University Hospital

OTHER

NCT03914404 - Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy | Biotech Hunter | Biotech Hunter